Fig. 4.
Management of post-transplant PTLD. RIS, reduction in immunosuppression; R-CHOP, Rituximab combined cyclophosphamide/doxorubicin/vincristine/prednisolone; ABVD, adriamycin/bleomycin/vinblastine/dacarbazine
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.